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ABSTRACT 
The present study involves preparation and evaluation of floating microspheres using Mebendazole (MBZ) as a model drug for 
improving the drug bioavailability by prolongation of gastric retention time.  Ethyl cellulose, hydroxyl propyl methyl cellulose 
microspheres loaded with mebendazole were prepared by solvent diffusion evaporation method. The microspheres had smooth 
surfaces, with free-flowing and good-packing properties. The yield of the microspheres was up to 85.65±0.14% and ethyl cellulose 
microspheres entrapped the maximum amount of the drug. Scanning electron microscopy confirmed their hollow structures with 
sizes in the range 215.1 to 251.80 nm. The prepared microspheres exhibited prolonged drug release and Percentage buoyancy was 
found to70.25±0.15. The formulated batches were evaluated for percentage yield, particle size measurement, flow properties, percent 
entrapment efficiency, swelling studies. The formulations were subjected to Stability studies and In-vitro release and Release 
kinetics data was subjected to different dissolution models. 
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INTRODUCTION 
Oral delivery of drugs is by far the most preferable route 
of drug delivery due to ease of administration, patient 
compliance and flexibility in formulation etc. From 
immediate release to site-specific delivery, oral dosage 
forms have really progressed. However, it is a well 
accepted fact that it is difficult to predict the real in vivo 
time of release with solid, oral controlled release dosage 
forms. Thus, drug absorption in gastrointestinal (GI) 
tract may be very short and highly variable in certain 
circumstances 
1, 2
. Several difficulties are faced in 
designing controlled release systems for better 
absorption and enhanced bioavailability. Various 
attempts have been made to prolong the retention time 
of the dosage form in the stomach. One such method is 
the preparation of a device that remains buoyant in the 
stomach contents due to its lower density than that of 
the gastric fluids 
3,4
. Single-unit formulations are 
associated with problems such as sticking together or 
being obstructed in the gastrointestinal tract, which may 
have a potential danger of producing irritation. On the 
other hand, a floating system made of multiple unit 
forms has relative merits compared to a single unit 
preparation. Indeed, the gastric emptying of a 
multiparticulate floating system would occur in 
consistent manner with small individual variations. On 
each subsequent gastric emptying, sunk particles will 
spread out over a large area of absorption sites, 
increasing the opportunity for drug release profile and 
absorption in a more or less predictable way. Moreover, 
since each dose consists of many subunits, the risk of 
dose dumping is reduced 
5, 6
. Mebendazole is a highly 
effective broad spectrum antihelmintic indicated for the 
treatment of nematode infestations, including 
roundworm, whipworm, threadworm, and hookworm. 
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When administered orally, only around 10% of the 
mebendazole is absorbed with peak plasma 
concentrations after 1 or 2 hours. 
7
 It has a short plasma 
half-life of 2.5 to 5.5 hours
8
, but this drug is less 
absorbed in the stomach and has the extensive hepatic 
metabolism. Therefore, it requires to be formulated in 
the improved form to get the improved bioavailability of 
drug and to reduce the frequency of dosing. The 
objective of the present work was to develop and 
characterize floating microspheres of Mebendazole, 
which after oral administration could prolong the gastric 
residence time and increase the drug bioavailability. 
MATERIAL AND METHODS 
Mebendazole was provided as gift sample from 
Pharmaceutical company. Dichloromethane, ethanol and 
isopropyl alcohol were purchased from E. Merck (India) 
Ltd., Mumbai. Ethyl cellulose, hydroxyl propyl methyl 
cellulose was purchased from Loba Chemie Pvt ltd, 
Mumbai All the other chemicals used were of analytical 
grade. 
Preparation of floating microspheres  
Floating microspheres loaded with Mebendazole were 
prepared using solvent diffusion evaporation method 
9
 
using Ethyl cellulose and hydroxyl propyl methyl 
cellulose. Drug and polymer in proportion of 1:2 were 
dissolved in 1:1 mixture of solvent system of, 
dichloromethane and ethanol. This clear solution was 
poured slowly in a thin stream into the aqueous solution 
of 1% polyvinyl alcohol. The emulsion was 
continuously stirred for 3 h at a speed of 500 rpm at 
27±2°C. The floating microspheres were collected by 
decantation, while the non-floating microspheres were 
discarded. The microspheres were dried overnight at 
40±2°C and stored in desiccator. 
Size and shape of microspheres 
The mean size of the microspheres was determined by 
photo correlation spectroscopy (PCS) on a submicron 
particle size analyzer (Horiba Instruments) at a 
scattering angle of 90°. A sample (0.5mg) of the 
microspheres suspended in 5 ml of distilled water was 
used for the measurement. The results of measurement 
of mean particle size of optimized formulation F4 of 
floating microsphere was found to be 215.1 nm. From 
the formulated batches of microspheres, formulations 
(F4) which showed an appropriate balance between the 
percentage releases were examined for surface 
morphology and shape using scanning electron 
microscope Jeol Japan 6000. Sample was fixed on 
carbon tape and fine gold sputtering was applied in a 
high vacuum evaporator. The acceleration voltage was 
set at 10KV during scanning. Microphotographs were 
taken on different magnification and higher 
magnification (200X) was used for surface morphology.   
Flow properties  
The flow properties of microspheres were characterized 
in terms of angle of repose, carr’s index and hausner 
ratio 
10. For determination of angle of repose (θ), the 
microspheres were poured through the walls of a funnel, 
which was fixed at a position such that its lower tip was 
at a height of exactly 2.0 cm above hard surface. The 
microspheres were poured till the time when upper tip of 
the pile surface touched the lower tip of the funnel. The 
tan-1 of the height of the pile / radius of its base gave 
the angle of repose. Microspheres were poured gently 
through a glass funnel into a graduated cylinder cut 
exactly to 10ml mark. Excess microspheres were 
removed using a spatula and the weight of the cylinder 
with pellets required for filling the cylinder volume was 
calculated. The cylinder was then tapped from a height 
of 2.0 cm until the time when there was no more 
decrease in the volume. Bulk density (ρb ) and tapped 
density (ρt ) were calculated. Hausner ratio (HR) and 
carr index (IC) were calculated according to the two 
equations given below: HR= ρt /ρb IC = (ρt% ρb )/ρt 
Floating behavior 
Ten milligrams of the floating microspheres were placed 
in 0.1 N HCl (100 mL). The mixture was stirred at 100 
rpm in a magnetic stirrer. After 10 h, the layer of 
buoyant microsphere was pipetted and separated by 
filtration. Particles in the sinking particulate layer were 
separated by filtration. Particles of both types were dried 
in desiccators until a constant weight was obtained. Both 
the fractions of microspheres were weighed and 
buoyancy was determined by the weight ratio of floating 
particles to the sum of floating and sinking particles 
2, 11
. 
                  
                             
             
      
Drug entrapment 
The various formulations of the Floating microspheres 
were subjected for drug content. 10 mg of Floating 
microspheres from all batches were accurately weighed 
and crushed. The powder of microspheres were 
dissolved in 10 ml 0.1 N HCl and centrifuge at 1000 
rpm. This supernatant solution is than filtered through 
whatmann filter paper No. 44. After filtration, from this 
solution 0.1 ml was taken out and diluted up to 10 ml 
with 0.1 N HCl. The percentage drug entrapment was 
calculated using calibration curve method.
12, 13
 
In-vitro release studies 
The drug release rate from Floating microspheres was 
carried out using the USP type II (Electro Lab.) 
dissolution paddle assembly. A weighed amount of 
Floating microspheres equivalent to 100 mg drug were 
dispersed in 900 ml of 0.1 N HCI (pH=1.2) maintained 
at 37 ± 0.5°C and stirred at 55rpm. One ml sample was 
withdrawn at predetermined intervals and filtered and 
equal volume of dissolution medium was replaced in the 
vessel after each withdrawal to maintain sink condition. 
The collected samples analyzed spectrophotometrically 
at 256 nm to determine the concentration of drug present 
in the dissolution medium.   
Determination of zeta potential 
The zeta potential of the drug-loaded microspheres was 
measured on a zeta sizer (Horiba Instruments) by 
determining the electrophoretic mobility in a micro 
electrophoresis flow cell. All the samples were 
measured in water at 25°C in triplicate.   
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RESULTS AND DISCUSSION 
The floating microspheres of mebendazole were 
prepared by solvent diffusion-evaporation method. 
Percentage yield of different formulation was 
determined by weighing the Microspheres after drying.  
The percentage yield of different formulation was in 
range of 73.25– 85.65%. Result shown in Table I. The 
prepared floating microspheres were found to be 
discrete, spherical and free flowing. Surface morphology 
characteristics were studied using SEM. SEM indicated 
that the prepared microspheres are spherical with 
smooth surface; distinct pores are evident on the surface 
of microspheres, which will be responsible for the 
release.  
 
Table 1: Percentage Yield for Different Formulation 
Formulation Percentage Yield* 
F1 80.25±0.25 
F2 83.35±0.32 
F3 85.65±0.14 
F4 79.98±0.45 
F5 73.25±0.58 
F6 79.98±0.74 
*n=3 Determination 
 
Angle of repose, hausner ratio, and carr index were 
determined to predict flowability. A higher Hausner 
ratio indicates greater cohesion between particles while 
a high Carr index is indicative of the tendency to form 
bridges. The prepared microspheres exhibited good flow 
properties and can be arranged as: F4 > F6 > F5 
Percentage incorporation efficiency was in the range of 
65.89±0.45% to 78.98±0.36%, F4 microspheres 
entrapped maximum amount of the drug. To assess the 
floating properties, the microspheres were placed in 
0.1N hydrochloric acid The microspheres floated for 
prolonged time over the surface of the dissolution 
medium without any apparent gelation. Buoyancy 
percentage of the microspheres was in the range of 
63.45±0.26to 70.25±0.15 at the end of 10 h. The nature 
of the polymer influenced the floating behaviour of the 
microspheres. The mean size of the microspheres was 
determined by photo correlation spectroscopy (PCS) on 
a submicron particle size analyzer (Horiba Instruments) 
at a scattering angle of 90°.The results of measurement 
of mean particle size of optimized formulation F4 of 
floating microsphere was found to be 215.1 nm (Figure 
2). 
Results of zeta potential of optimized formulation F4 of 
floating microsphere was found -36mV (Figure 3). 
The drug release from floating microspheres was found 
to be 99.78% at the end of 12 h for F4 (Figure4). The 
data obtained from in vitro dissolution studies were 
fitted to zero-order, first-order (Table 2) 
 
 
Figure 2: Particle size data of optimized microsphere 
formulation F4 
 
Figure 3: Zeta potential data of floating microsphere 
 
Figure 4: Graph of release study of formulation F1-
F6 
Table 2: Comparative study of regression coefficient 
for selection of optimized Formulation F-4 
Release Kinetics Zero 
order 
First order 
R
2
 Microsphere 0.881 0.904 
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The In vitro drug release data of the optimized 
formulation was subjected to goodness of fit test by 
linear regression analysis according to zero order, first 
order kinetic equation, in order to determine the 
mechanism of drug release. When the regression 
coefficient values were compared, it was observed that 
‘r’ values of microsphere was maximum first order i.e 
0.904 hence indicating drug release from formulations 
was found to follow first order for floating microsphere.  
CONCLUSION 
Drug absorption in the gastrointestinal tract is a highly 
variable process. Floating microspheres are promises to 
be a potential approach for gastric retention enhances 
the bioavailability and controlled delivery of various 
therapeutic agents. Significant attempts have been made 
worldwide to explore these systems according to patient 
requirements, both in terms of therapeutic efficacy and 
compliance. Floating microspheres of mebendazole as 
gastro retentive dosage forms precisely control the 
release rate of target drug to a specific site and facilitate 
an enormous impact on health care. These systems also 
provide tremendous opportunities in the designing of 
new controlled and delayed release oral formulations, 
thus extending the frontier of futuristic pharmaceutical 
development. Furthermore, recent innovations in 
pharmaceutical investigation will surely provide real 
prospects for establishment of novel and effective means 
in the development of these promising drug delivery 
systems.
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